Drugmaker Wins Appeal On Myeloma Treatment Authorization
A European Union court on Wednesday overturned a decision preventing a Spanish biopharmaceutical company from putting its oncology drug on the market, finding that two experts who weighed in on the...To view the full article, register now.
Already a subscriber? Click here to view full article